| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69097-890-67 | 69097-890 | HUMAN PRESCRIPTION DRUG | Lanreotide Acetate | lanreotide acetate | INJECTION | SUBCUTANEOUS | 20211224 | N/A | NDA | NDA215395 | Cipla USA Inc. | LANREOTIDE ACETATE | 90 mg/.3mL | 1 SYRINGE in 1 CARTON (69097-890-67) / .3 mL in 1 SYRINGE |
| 69097-880-67 | 69097-880 | HUMAN PRESCRIPTION DRUG | Lanreotide Acetate | lanreotide acetate | INJECTION | SUBCUTANEOUS | 20211224 | N/A | NDA | NDA215395 | Cipla USA Inc. | LANREOTIDE ACETATE | 60 mg/.2mL | 1 SYRINGE in 1 CARTON (69097-880-67) / .2 mL in 1 SYRINGE |
| 69097-870-67 | 69097-870 | HUMAN PRESCRIPTION DRUG | Lanreotide Acetate | lanreotide acetate | INJECTION | SUBCUTANEOUS | 20211224 | N/A | NDA | NDA215395 | Cipla USA Inc. | LANREOTIDE ACETATE | 120 mg/.5mL | 1 SYRINGE in 1 CARTON (69097-870-67) / .5 mL in 1 SYRINGE |